LifeBond, Ltd.: Series C $20M

Posted in I - Series C, Q - 3Q11, R - INTERNATIONAL, X - Coagulation, X - Device (Hemostat)

LifeBond (Israel) a clinical-stage medical device company focused on surgical hemostats, sealants and coagulation, closed a $20M Series C financing. Participants include Giza Venture Capital, Aurum Ventures, Johnson & Johnson Development Corp. and Pitango Venture Capital.
Thanx for your patience as we catch-up.

Mar

2010

Eleven Biotherapeutics, Inc.: Series A $35M

Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - Coagulation, X - Inflammation, XX - MA

Eleven Biotherapeutics (Cambridge, MA) a preclinical-stage biopharmaceutical company focused on protein therapeutics for the treatment of inflammation and coagulation disorders, closed a $35M Series A financing. Participants include Flagship Ventures and Third Rock Ventures.
_________________________________________________________________________
NOTE: New OnBioVC Friday feature coming, well…this Friday!

to top of page...